Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Investigating the Effects of Cannabidiol on Social Anxiety Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Massachusetts Institute of Technology is investigating the effects of cannabidiol on social anxiety disorder, and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Massachusetts Institute of Technology | Conditions: Phobia, Social | Phase 4 | Status: RECRUITING